Blog

Jul 28, 2023

DCB Hematology, and Etiology Research

Posted by in category: biotech/medical

Part of NCI’s Division of Cancer Biology’s research portfolio, studies supported include the characterization of basic mechanisms relevant to anti-tumor immune responses and hematologic malignancies.

Comments are closed.